EP3435996
ELAFÍBRANOR TIL AÐ NOTA Í MEÐFERÐ VIÐ FRUMKOMINNI GALLRÁSARBÓLGU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.3.2017EP published:
30.4.2025EP application number:
17713332.9
EP translation filed:
21.7.2025Grant published:
15.8.2025EPO information:
European Patent Register
Max expiry date:
29.3.2037Expiry date:
29.3.2027Next due date:
31.3.2027
Title in English:
ELAFIBRANOR FOR USE IN THE TREATMENT OF PRIMARY BILIARY CHOLANGITISLanguage of the patent:
English
Timeline
Today
30.3.2017EP application
30.4.2025EP Publication
21.7.2025Translation submitted
15.8.2025Registration published
29.3.2027Expires
Owner
Name:
GenfitAddress:
885, Avenue Eugène Avinée, 59120 Loos, FR
Inventor
Name:
HANF, RémyAddress:
59000 LILLE, FR
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
16305381Date:
31.3.2016Country:
EP
Supplementary protection
SPC number:
SPC526
Classification
Categories:
A61K 31/192, A61P 1/16, A61K 9/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 24.2.2026
Expires: 29.3.2027
Payer: Acumass